Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients
M Megna, E Camela, T Battista, L Genco… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction The management of moderate-to-severe forms of psoriasis is becoming a
frequent concern in geriatric age due to the higher risk to develop treatment adverse events …
frequent concern in geriatric age due to the higher risk to develop treatment adverse events …
Treatment of psoriasis patients with latent tuberculosis using IL-17 and IL-23 inhibitors: a retrospective, multinational, multicentre study
T Torres, A Chiricozzi, L Puig, AM Lé… - American Journal of …, 2024 - Springer
Background Tuberculosis has a major global impact. Immunocompetent hosts usually
control this disease, resulting in an asymptomatic latent tuberculosis infection (LTBI) …
control this disease, resulting in an asymptomatic latent tuberculosis infection (LTBI) …
Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real‐world practice
J Zhou, Y Yuan, Y Liu, M Chu, H Liu… - Experimental …, 2024 - Wiley Online Library
A number of randomized controlled trials and real‐world studies have demonstrated the
effectiveness and safety of secukinumab in the treatment of moderate to severe psoriasis …
effectiveness and safety of secukinumab in the treatment of moderate to severe psoriasis …
Management of Psoriasis Patients with Serious Infectious Diseases
M Megna, G Lauletta, N Tommasino, A Salsano… - Advances in …, 2024 - Springer
The management of patients affected by moderate-to-severe psoriasis may be challenging,
in particular in patients with serious infectious diseases [tuberculosis (TB), hepatitis B and C …
in particular in patients with serious infectious diseases [tuberculosis (TB), hepatitis B and C …
No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: multicenter case series of 35 …
N Manzanares, E Vilarrasa, A López… - Journal of the …, 2024 - pubmed.ncbi.nlm.nih.gov
No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite
untreated latent tuberculosis infection: Multicenter case series of 35 patients No tuberculosis …
untreated latent tuberculosis infection: Multicenter case series of 35 patients No tuberculosis …
A propensity score-matched study on the changes of TB status and TB-IGRA values in patients with psoriasis with latent TB receiving secukinumab
Y Xiao, W Mi, J Wang, D Wen, Y Wang, Y Gu… - Dermatology and …, 2023 - Springer
Introduction The utilization of biologics in patients with psoriasis with latent tuberculosis
infection (LTBI) has garnered significant attention. Although the tuberculosis (TB) safety …
infection (LTBI) has garnered significant attention. Although the tuberculosis (TB) safety …
Safety of secukinumab in the treatment of patients with axial spondyloarthritis and concurrent hepatitis B virus infection or latent tuberculosis infection
S Liu, Z He, W Wu, H Jin, Y Cui - Clinical Rheumatology, 2023 - Springer
Objective To evaluate the safety of secukinumab (SEC) in the treatment of patients with axial
spondyloarthritis (axSpA) and concurrent hepatitis B virus (HBV) infection or latent …
spondyloarthritis (axSpA) and concurrent hepatitis B virus (HBV) infection or latent …
Reply to “Routine rescreening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: A single …
A Ruggiero, L Potestio, E Camela, G Fabbrocini… - Journal of the American …, 2022 - jaad.org
REFERENCES 1. Khanna U, Gallop J, Ellis A, et al. Routine rescreening for latent
tuberculosis has low utility in patients with chronic immunemediated inflammatory diseases …
tuberculosis has low utility in patients with chronic immunemediated inflammatory diseases …
[HTML][HTML] Vitamin D May Be Connected with Health-Related Quality of Life in Psoriasis Patients Treated with Biologics
IA Paliu, SL Ianosi, A Turcu-Stiolica… - Journal of Personalized …, 2022 - mdpi.com
Suboptimal states of vitamin D may play a role in psoriasis evolution, but the
interconnections have been studied over the past years with controversial results. Although …
interconnections have been studied over the past years with controversial results. Although …
Conceptos actuales del diagnóstico y tratamiento de la artritis psoriásica
JC Santacruz, MJ Mantilla… - Gaceta Médica de …, 2023 - saber.ucv.ve
La artritis psoriásica (APs) es una enfermedad autoinmune sistémica asociada a la
psoriasis, conocida ahora dentro de un único espectro llamado enfermedad psoriásica, y …
psoriasis, conocida ahora dentro de un único espectro llamado enfermedad psoriásica, y …